Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
Public ClinicalTrials.gov record NCT00095524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind Study on the Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.
Study identification
- NCT ID
- NCT00095524
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2004 (Type not available)
- Primary completion
- Aug 2006 (Actual)
- Completion
- Aug 2006 (Actual)
- Last update posted
- Nov 11, 2013
2004 – 2006
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Anaheim | California | — | — |
| Local Institution | Cerritos | California | — | — |
| Local Institution | Garden Grove | California | — | — |
| Local Institution | National City | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | New Britain | Connecticut | — | — |
| Local Institution | North Miami | Florida | — | — |
| Local Institution | Augusta | Georgia | — | — |
| Local Institution | Macon | Georgia | — | — |
| Local Institution | Hoffman Estates | Illinois | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Glen Burnie | Maryland | — | — |
| Local Institution | Haverhill | Massachusetts | — | — |
| Local Institution | Worcester | Massachusetts | — | — |
| Local Institution | Minneapolis | Minnesota | — | — |
| Local Institution | Brooklyn | New York | — | — |
| Local Institution | Nashville | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | DeSoto | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2013 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00095524 live on ClinicalTrials.gov.